2023 Q3 Form 10-Q Financial Statement
#000164033423002137 Filed on November 14, 2023
Income Statement
Concept | 2023 Q3 | 2022 Q3 |
---|---|---|
Revenue | $0.00 | |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $10.31K | |
YoY Change | -6.67% | |
% of Gross Profit | ||
Research & Development | $9.500K | |
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $3.110K | |
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $1.334K | -$19.81K |
YoY Change | -106.74% | -279.28% |
Operating Profit | -$1.334K | -$20.12K |
YoY Change | -93.37% | 82.1% |
Interest Expense | $393.00 | -$310.00 |
YoY Change | -226.77% | |
% of Operating Profit | ||
Other Income/Expense, Net | -$393.00 | -$312.00 |
YoY Change | 25.96% | |
Pretax Income | -$20.12K | |
YoY Change | 117.75% | |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$1.727K | -$20.12K |
YoY Change | -91.42% | 98.28% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.00 | -$2.022K |
COMMON SHARES | ||
Basic Shares Outstanding | 9.948M shares | 9.948M shares |
Diluted Shares Outstanding | 9.948M shares |
Balance Sheet
Concept | 2023 Q3 | 2022 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $0.00 | $0.00 |
Short-Term Investments | ||
Other Short-Term Assets | $9.890K | |
YoY Change | ||
Inventory | ||
Prepaid Expenses | $0.00 | $9.889K |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $9.890K | |
YoY Change | -37.88% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | -$1.00 | |
YoY Change | -66.67% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $9.890K | |
Total Long-Term Assets | -$1.00 | |
Total Assets | $0.00 | $9.889K |
YoY Change | -100.0% | -37.87% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $0.00 | |
YoY Change | -100.0% | |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $54.53K | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $86.72K | $54.53K |
YoY Change | 59.03% | 1043.19% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $86.72K | $54.53K |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $86.72K | $54.53K |
YoY Change | 59.04% | 1044.34% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$129.6K | -$87.51K |
YoY Change | 48.09% | -39.82% |
Common Stock | $995.00 | $995.00 |
YoY Change | 0.0% | -2.64% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$86.72K | -$44.64K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $0.00 | $9.889K |
YoY Change | -100.0% | -37.87% |
Cashflow Statement
Concept | 2023 Q3 | 2022 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.727K | -$20.12K |
YoY Change | -91.42% | 98.28% |
Depreciation, Depletion And Amortization | $3.110K | |
YoY Change | ||
Cash From Operating Activities | -$16.79K | |
YoY Change | -117.46% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | |
YoY Change | -100.0% | |
Cash From Investing Activities | $0.00 | |
YoY Change | -100.0% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 16.79K | |
YoY Change | -120.04% | |
NET CHANGE | ||
Cash From Operating Activities | -16.79K | |
Cash From Investing Activities | 0.000 | |
Cash From Financing Activities | 16.79K | |
Net Change In Cash | 0.000 | |
YoY Change | -100.0% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$16.79K | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-61403 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1727 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-25317 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-32509 | usd | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-61403 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-12130 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-32509 | usd | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-44639 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-32509 | usd | |
us-gaap |
Depreciation
Depreciation
|
5967 | usd | |
us-gaap |
Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-6063 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-35149 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
24183 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
0 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p> | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
38 S Federal Highway #10-199 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001794942 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
9948330 | shares |
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
32-0610316 | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
#10-199 | ||
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9948330 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9948330 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9948330 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
333-237100 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
STARK FOCUS GROUP INC. | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dania Beach | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33004 | ||
dei |
City Area Code
CityAreaCode
|
352 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
562 - 0289 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
5967 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
0 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
5967 | usd |
CY2023Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
0 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
6000 | usd |
CY2023Q3 | us-gaap |
Debt Current
DebtCurrent
|
14872 | usd |
CY2022Q4 | us-gaap |
Debt Current
DebtCurrent
|
0 | usd |
CY2023Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
71848 | usd |
CY2022Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
47665 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
86720 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
53665 | usd |
CY2023Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
0 | usd |
CY2022Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
13705 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
86720 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
67370 | usd |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
995 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
995 | usd |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
41879 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
41879 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-129594 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-104277 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-86720 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5967 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1334 | usd |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7614 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
24150 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
20006 | usd | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9500 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9500 | usd | |
CY2022Q3 | us-gaap |
Advertising Expense
AdvertisingExpense
|
2691 | usd |
us-gaap |
Advertising Expense
AdvertisingExpense
|
2691 | usd | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1334 | usd |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19805 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24150 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-32197 | usd | |
CY2023Q3 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
393 | usd |
CY2022Q3 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
312 | usd |
us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
1167 | usd | |
us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
312 | usd | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-393 | usd |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-312 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1167 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-312 | usd | |
CY2023Q3 | stark |
Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
|
-0.00 | |
CY2022Q3 | stark |
Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
|
-0.01 | |
stark |
Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
|
-0.00 | ||
stark |
Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
|
-0.01 | ||
CY2023Q3 | stark |
Weighted Average Number Of
WeightedAverageNumberOf
|
9,948,330 | |
CY2022Q3 | stark |
Weighted Average Number Of
WeightedAverageNumberOf
|
9,948,330 | |
stark |
Weighted Average Number Of
WeightedAverageNumberOf
|
9,948,330 | ||
stark |
Weighted Average Number Of
WeightedAverageNumberOf
|
9,948,330 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-25317 | usd | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-86720 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-25317 | usd | |
us-gaap |
Depreciation
Depreciation
|
3111 | usd | |
us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
1167 | usd | |
us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
312 | usd | |
us-gaap |
Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-6000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-24183 | usd | |
us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
24183 | usd | |
us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
35149 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
35149 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
0 | usd | |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
86720 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-129594 | usd |
us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
1167 | usd | |
CY2023Q3 | us-gaap |
Loans Payable
LoansPayable
|
71848 | usd |
CY2022Q4 | us-gaap |
Loans Payable
LoansPayable
|
47665 | usd |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9948330 | shares |